Neoplasms by Histologic Type  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00201396: A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Completed
3
480
RoW
CCRT, Mitomycin C,Epirubicin,Cisplatin,5-Fluorouracil,Leucovorin
National Health Research Institutes, Taiwan, National Taiwan University Hospital, Tri-Service General Hospital, Chang Gung Memorial Hospital, China Medical University Hospital, Chung Shan Medical University, Changhua Christian Hospital, Chi Mei Medical Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Veterans General Hospital., Taipei Veterans General Hospital, Taiwan
Nasopharyngeal Carcinoma
08/09
12/11
NCT00658580: Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

Completed
3
361
Europe
Cisplatin + etoposide, Epirubicin + ifosfamide + etoposide
European Lung Cancer Working Party
Small Cell Lung Carcinoma, Extensive Disease
12/13
02/15
RILOMET-1, NCT01697072 / 2011-004923-11: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Terminated
3
609
US, Canada, Europe, RoW
Rilotumumab, AMG102, Placebo, sterile protein-free solution, Epirubicin, Ellence, Pharmorubicin PFS, Pharmorubicin RDF, Cisplatin, Platinol, Platinol-AQ, Capecitabine, Xeloda
Amgen
Gastric Cancer
11/14
08/15
NCT01204437 / 2008-003995-23: Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast

Checkmark EBCC 2014
Mar 2014 - Mar 2014: EBCC 2014
Completed
2/3
400
Europe
Epirubicin, Cyclophosphamide, Cyclophosphamide, Methotrexate, 5 FU, Capecitabine, Nab-Paclitaxel
German Breast Group
Breast Cancer
01/14
01/14

Download Options